Physician

David Allan Couch, M.D.

According to 2025 Medicare claims, David Couch, M.D. (NPI: 1659377679) practices ophthalmology in the Kingsport-Bristol, TN-VA market, with the plurality of this provider's patient population coming from Sullivan, TN. This provider's primary affiliated billing organization is SOUTHEASTERN RETINA ASSOCIATES, P.C. (NPI: 1932370145; TIN: 621094813) and primary practice location at 37660-4772.

Couch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 378 traditional Medicare patients, billed 13,346 HCPCS/CPT codes, and received $1,618,163 in Medicare payments. The top billing code was Q5128 (Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg). Part D data shows 381 prescription claims across 131 beneficiaries totaling $5,539 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $15,246 and ending at $5,539. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.1M2015 Medicare payment: $1,806,443 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,034,500 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,755,038 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,141,763 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,825,182 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,714,180 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,626,506 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,507,120 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,361,309 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,618,163 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201566012,211$1,806,443
201671114,965$2,034,500
201769611,129$1,755,038
201861412,781$2,141,763
201962512,156$1,825,182
202053610,302$1,714,180
20214829,715$1,626,506
20224439,256$1,507,120
20234089,845$1,361,309
202437813,346$1,618,163

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.6K$15K2015 Drug cost: $15,246 (USD; Tot_Drug_Cst)2016 Drug cost: $6,791 (USD; Tot_Drug_Cst)2017 Drug cost: $10,043 (USD; Tot_Drug_Cst)2018 Drug cost: $11,529 (USD; Tot_Drug_Cst)2019 Drug cost: $8,833 (USD; Tot_Drug_Cst)2020 Drug cost: $10,611 (USD; Tot_Drug_Cst)2021 Drug cost: $12,154 (USD; Tot_Drug_Cst)2022 Drug cost: $9,027 (USD; Tot_Drug_Cst)2023 Drug cost: $10,775 (USD; Tot_Drug_Cst)2024 Drug cost: $5,539 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015105345$15,246
201682247$6,791
2017112349$10,043
2018122331$11,529
2019106294$8,833
2020103275$10,611
202196317$12,154
2022130370$9,027
2023139402$10,775
2024131381$5,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg1083,536$180
92014Established patient complete exam of visual system170195$91
67028Injection of drug into eye1971,337$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more179210$70
92134Imaging of retina3651,342$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate271,074$1,455
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha921,477$1,182
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen93286$389
Ketorolac TromethamineKetorolac Tromethamine11320$322
Brimonidine TartrateBrimonidine Tartrate382,772$251

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for David Allan Couch, M.D.?

Tedicare shows public-source Medicare data for David Allan Couch, M.D. (NPI 1659377679), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Allan Couch, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Allan Couch, M.D.?

David Allan Couch, M.D. is linked to SOUTHEASTERN RETINA ASSOCIATES, P.C. (billing NPI 1932370145) in the available physician profile data.

Does David Allan Couch, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.